Description
A PLA2 inhibitor (IC50 = 40 µM in human neutrophils); inhibits human synovial fluid PLA2-induced edema in a dose-dependent manner in vivo; inhibits hemolytic activity of the PLA2 enzymes TFV PL-X, TFV PL-Ia, and TFV PL-Ib from T. flavoviridis venom (IC50s = 4.6, 4.0, and 3.9 µM, respectively); enhances the edema-inducing activity of TFV PL-Ia and TFV PL-Ib; associated with progressive interstitial fibrosing nephropathy and upper urinary tract urothelial carcinomas
Formal name: 8-methoxy-6-nitro-phenanthro[3,4-d]-1,3-dioxole-5-carboxylic acid
Synonyms: Aristolochic Acid A|Aristolochic acid I|NSC 11926|NSC 50413|Tardolyt
Molecular weight: 341.3
CAS: 313-67-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Natural Products|Alkaloids||Product Type|Biochemicals|Small Molecule Inhibitors|Phospholipases||Research Area|Cancer||Research Area|Lipid Biochemistry|Glycerophospholipids|Phospholipases||Research Area|Toxicology|Environmental